All articles
How GLP-1s are Changing Restaurant Menus and Food Companies
Reading time:
14 min
Weight loss
Get expert guidance and a personalized care plan designed around you.
The Protein Priority Reshapes Product Development
One of the clearest trends driven by GLP-1 adoption is the protein arms race across food categories. When you eat less total food, getting adequate protein becomes challenging. Clinicians commonly encourage people losing weight to pay attention to protein intake, and what is appropriate varies by person (7). Meeting that intake while eating substantially smaller volumes takes deliberate focus on protein-dense foods.
Food manufacturers are responding by adding protein to everything. Categories that were never particularly protein-focused now feature high-protein variants. Bread with added protein. Pasta with extra protein. Snack bars that are essentially protein delivery vehicles. Ready-to-drink protein shakes have moved from the supplement section to mainstream beverage coolers.
This shift benefits some companies more than others. Dairy producers have found new demand for Greek yogurt, cottage cheese, and other high-protein dairy products. Meat and poultry companies are launching new convenience-oriented products designed for quick protein consumption. Plant-based protein manufacturers are positioning their products as solutions for GLP-1 users who need protein but have a reduced appetite for higher fat animal products.
The challenge for food companies is balancing protein content with palatability and digestibility. GLP-1 users often struggle with very rich or heavy foods (4,10). A protein bar with 20 grams of protein but high fat content may be nutritionally appropriate but difficult to consume comfortably. This has driven innovation toward lighter textures, less fat, and more easily digestible protein sources.
Financial Impacts Ripple Through the Food Sector
The stock market has begun pricing in GLP-1 impact on food companies. When major retailers like Walmart publicly stated that GLP-1 users were buying less food, shares of snack food companies, soft drink manufacturers, and packaged food producers came under pressure (1,2).
This vulnerability is not evenly distributed: companies heavily invested in indulgent, high-calorie products face the greatest risk, since calorie-dense snacks and sweets show the steepest spending declines (6). Snack food manufacturers, candy companies, and soft drink producers are all contending with a customer base that has reduced desire for their core products. Some are attempting to diversify into healthier product lines, while others are focusing on international markets where GLP-1 adoption remains lower (3,9).
Conversely, some food companies view the GLP-1 trend as opportunity rather than threat. The market for meal replacement products, nutritional supplements, and health-focused prepared foods is expanding rapidly (9). Companies that already had strong positions in these categories are experiencing growth. Those pivoting successfully from traditional to more nutrient-dense products are being rewarded by both consumers and investors.
The pressure extends beyond public companies to restaurants and food service providers. Anecdotal reports from restaurant operators suggest declining per-customer food consumption (11). Some establishments report that average check sizes are declining even as traffic remains stable or increases, suggesting customers are ordering less food per visit.
Consumer Experience Challenges Persist Despite Industry Changes
Even as restaurants and food companies adapt, GLP-1 users continue facing practical challenges when dining out or shopping for groceries. The pace of industry change has not yet caught up with the reality of dramatically reduced appetites and changed food preferences.
Restaurant dining remains socially complicated for many users. Ordering a full entree and leaving most of it uneaten feels wasteful and can draw unwanted attention or questions. Requesting smaller portions or attempting to order from the children's menu as an adult can feel awkward. Many restaurants still lack true half-portion options with proportionally reduced prices, even though 72 percent of GLP-1 users in the Toast survey said they want a smaller-portion option (11). Servers may not understand why customers are leaving so much food and may repeatedly ask if something is wrong with the meal.
Grocery shopping presents its own challenges. The economics of food packaging often penalize those buying for one person with a small appetite. Per-unit costs for single-serve portions are substantially higher than for family sizes. Perishable items like fresh vegetables and proteins come in quantities that are difficult to consume before spoilage when appetite is dramatically reduced. Many GLP-1 users report needing to shop more frequently for smaller quantities, which increases both time investment and transportation costs. Concerns about limiting processed foods can create confusion around incorporating items such as frozen vegetables and prepared protein foods.
Social eating situations remain difficult to navigate. Family dinners where everyone else is eating normal portions can make GLP-1 users feel conspicuous about their small plates, worrying it may seem as if they are ungrateful for the food or effort. Ordering at restaurants with friends who want to share multiple dishes creates logistical complications when you can only eat a few bites. In any of these situations, declining foods offered by family members or at social gatherings can require repeated explanations that feel tiresome or invasive depending on whether users want to disclose their medication use.
Marketing Approaches to a Medication-Influenced Market
Food companies face a delicate marketing challenge. GLP-1 users represent a large and growing consumer segment with specific needs, but explicitly marketing to them risks several problems. It might alienate other customers. It could attract regulatory scrutiny if perceived as encouraging medication use. It makes the brand identity explicitly medical rather than lifestyle-oriented.
The solution most companies have adopted is coded language that GLP-1 users recognize while remaining accessible to broader audiences (3). Terms such as portion-control friendly, protein-first, right-sized, and nutritionally dense signal to GLP-1 users that products meet their needs without explicitly stating the connection. Marketing imagery emphasizes smaller portions as sophisticated rather than restrictive, positioning reduced eating as a positive lifestyle choice rather than a medication side effect.
Social media has become crucial for reaching GLP-1 users directly. Influencers documenting their weight loss journeys regularly feature specific products and restaurants that work well with reduced appetites. Food companies are increasingly partnering with these influencers. User-generated content showing how to make GLP-1-friendly meals with specific products provides organic marketing that feels more authentic than corporate advertising. This has made it increasingly important to work with a nutrition expert such as a Registered Dietitian to differentiate between what just sounds good and what is sound nutrition advice.
Some companies are experimenting with more direct approaches in digital spaces. Targeted advertising on health and wellness platforms can reach likely GLP-1 users without broadcasting the association broadly. Recipe content optimized for smaller portions and higher protein appears on brand websites and social channels. Community building efforts create spaces where GLP-1 users can share experiences and product recommendations, with brands participating in these conversations in carefully moderated ways.
The long-term question is when and whether GLP-1 friendly becomes an explicit marketing category like gluten-free or keto. Some industry observers believe this transition is inevitable as the population taking these medications grows large enough that the association loses its clinical connotation and becomes simply a descriptor of food characteristics.
Future Projections for Industry Evolution
The changes visible now likely represent only the beginning of a much larger transformation in how food is produced, marketed, and consumed in America. As GLP-1 adoption continues to grow, the ripple effects will touch every aspect of the food system.
Restaurant concepts specifically designed for lighter eating will likely emerge. These would feature entirely small-plate menus, flexible pricing that makes ordering multiple small items economical, and social environments that normalize reduced eating rather than overindulgence. Some industry analysts predict that within five years, major metropolitan areas will have restaurant chains explicitly positioning themselves as optimal for GLP-1 users, though likely using lifestyle rather than medical terminology.
Grocery stores may create dedicated sections for portion-controlled and protein-dense products, similar to how organic and gluten-free products gained their own sections as those markets grew. The frozen food aisle could be reorganized entirely around single-serve options rather than treating them as exceptions. Prepared food sections might expand as GLP-1 users find that buying small amounts of ready-to-eat food makes more sense than purchasing ingredients that may spoil before they can be consumed.
Food delivery services represent a major opportunity for innovation. Services specifically designed around smaller, more frequent deliveries for reduced appetites could differentiate themselves in a crowded market. Subscription models that send appropriate portions of fresh food daily or several times weekly solve the spoilage problem while generating predictable revenue. Dynamic pricing that makes small orders economically viable would remove a major pain point in the current delivery experience.
Technology integration seems likely to increase. Apps that help GLP-1 users track protein intake and find appropriate portion sizes at restaurants would fill a clear need. Artificial Intelligence features that show how much of a restaurant dish represents an appropriate portion could help users navigate dining out more confidently. Delivery apps that default to half portions for users who opt into that preference would smooth the ordering experience.
The fundamental business models of food companies may need to evolve. The traditional approach of driving revenue through volume becomes less viable when a substantial portion of your customer base is eating less. Some companies may shift toward premium positioning, charging significantly more for smaller, higher-quality portions. Others may diversify into services and experiences around food rather than just selling food products themselves.
Practical Strategies for Navigating the Current Landscape
For individuals taking GLP-1 medications, successfully managing restaurant dining and grocery shopping requires deliberate strategies until the industry catches up more fully with their needs. The current environment offers more options than existed even a year ago, but gaps remain.
Researching restaurants prior to arrival makes dining out more successful and enjoyable. Many establishments now list detailed nutritional information online, which helps identify dishes that will work well for people with reduced appetites and changed preferences (12). Calling ahead to ask about smaller portion availability or policies on splitting entrees eliminates awkward negotiations with servers during the meal. Some users find it helpful to explain their situation briefly to servers, while others prefer simply requesting small portions without elaboration. It also helps to read what providers wish patients knew before starting.
Strategic ordering approaches reduce waste and frustration. Ordering two appetizers instead of an entree provides appropriate portion sizes while offering variety. Requesting a takeout container at the start of the meal and immediately portioning out a small serving to eat makes leaving the rest feel more intentional and still gives you the satisfaction of feeling like you finished your meal. Focusing on protein-centered dishes and vegetable sides rather than carbohydrate-heavy options tends to work better with GLP-1 effects (7).
Grocery shopping requires rethinking traditional approaches. Buying fresh foods more frequently in smaller quantities reduces waste despite potential higher per-unit costs and increased shopping trips. Utilizing grocery store prepared food sections and salad bars allows purchasing exactly the amounts needed. Building meals from components rather than following traditional recipes that assume conventional appetites prevents over-purchasing. Investing in quality food storage systems extends the useful life of items when consumption is slower than normal.
Social situation navigation becomes easier with practice. Being direct with close friends and family about the medication and its effects eliminates the need for repeated explanations. For more casual social contexts, having simple phrases ready like "I'm working with my doctor on a health program that means eating smaller portions" provides explanation without inviting extensive discussion. Suggesting prescreened restaurants that offer small plates or easily shared options makes group dining more comfortable.
FAQs
Which restaurants offer smaller portions for GLP-1 users?
Several chains have introduced lighter portion options on select menu items, and operators have reported rising requests for kid-size portions from adult customers, though no major chain has created an official smaller adult tier. Several fast-food chains now sell snack-size versions of popular items that GLP-1 users order as full meals (8). Full-service restaurants tend to be the most accommodating, because appetizers and small plates already fit their format.
How much less do people eat on GLP-1 medications?
Intake varies widely from person to person, and published estimates differ depending on how it is measured. The medications slow how quickly food leaves the stomach and reduce appetite signals, so fullness can arrive after just a few bites (4,10). Many people also find that rich, fatty, or heavily processed foods become unappealing or uncomfortable in a way they were not before (11).
What should you order at a restaurant when eating on a GLP-1?
Ordering two appetizers instead of an entree gives you an appropriate portion with more variety. Asking for a takeout container at the start of the meal and portioning out a small serving right away makes leaving the rest feel deliberate. Protein-centered dishes with vegetable sides tend to sit better than carbohydrate-heavy options (7).
How do you grocery shop with a much smaller appetite?
Buying fresh food more often in smaller amounts cuts waste, even though the per-unit cost is higher and it means more trips. Prepared food counters and salad bars let you buy exactly what you need. Building meals from components rather than following recipes written for conventional appetites helps avoid over-purchasing.
Check Your Eligibility
If you want to learn whether GLP-1 treatment may be appropriate for you, you can start by completing Mochi's eligibility questionnaire. It takes just a few minutes and helps affiliated Mochi Medical providers understand your goals and health history. Check your eligibility here.
References
Bloomberg. (2023, October 4). Ozempic is making people buy less food, Walmart says. https://www.bloomberg.com/news/articles/2023-10-04/walmart-says-ozempic-weight-loss-drugs-causing-slight-pullback-by-shoppers
Bloomberg. (2023, October 6). Ozempic threat is spurring a slump in snack and beer stocks. https://www.bloomberg.com/news/articles/2023-10-06/ozempic-threat-is-causing-a-selloff-in-candy-and-beer-stocks
Conagra Brands. (2024, December). Conagra Brands introduces badges on select Healthy Choice products, leading consumers to GLP-1-friendly options [Press release]. https://www.conagrabrands.com/news-room/news-conagra-brands-introduces-badges-on-select-healthy-choice-products-leading-consumers-to-glp-1-friendly-options-prn-122909
Eli Lilly and Company. (2023). Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration.
Gallup. (2026). In U.S., GLP-1 usage reaches new high. Gallup Panel survey of 5,065 U.S. adults, May 28 to June 5, 2026. https://news.gallup.com/poll/712157/glp-usage-reaches-new-high.aspx
Hristakeva, S., Liaukonytė, J., & Feler, L. (2026). The no-hunger games: How GLP-1 medication adoption is changing consumer food demand. Journal of Marketing Research, 63(3), 427-444. https://doi.org/10.1177/00222437251412834
Mozaffarian, D., et al. (2025). Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. https://doi.org/10.1002/oby.24336
NBC News. (2026, April 1). Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus. https://www.nbcnews.com/news/us-news/smaller-portions-protein-glp-1s-are-quietly-changing-chain-restaurant-rcna254178
Nestlé USA. (2024, May 21). Nestlé introduces Vital Pursuit brand to support GLP-1 users, consumers focused on weight management [Press release]. https://www.nestleusa.com/media/pressreleases/vital-pursuit-glp-1
Novo Nordisk. (2023). Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration.
Toast. (2026, October). Are GLP-1 users eating out less, or just ordering less? Survey of 850 U.S. adults taking a GLP-1, distributed by Stacker. https://krdo.com/stacker-food-drink/2026/10/02/are-glp-1-users-eating-out-less-or-just-ordering-less/
U.S. Food and Drug Administration. (n.d.). Menu labeling requirements. https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/menu-labeling-requirements
Young, L. R., & Nestle, M. (2002). The contribution of expanding portion sizes to the US obesity epidemic. American Journal of Public Health, 92(2), 246-249.
This article is for informational purposes only and does not constitute medical advice. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results are not guaranteed and may vary from person to person. GLP-1 medications require a written prescription from a licensed provider. Speak with a provider to determine if a GLP-1 medication is appropriate for you. Medications prescribed through the Mochi platform may include compounded formulations. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Medications are filled and distributed by independently owned and licensed pharmacies. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices.
Share this post
Weight loss
More articles
